CLGM
TERN

Capitolis Liquid Global Markets’s Terns Pharmaceuticals TERN Stock Holding History

Capitolis Liquid Global Markets’s Portfolio TERN Stock Details TERN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-1,975,800
Closed -$104M – 390
2026
Q1 		$104M Sell
1,975,800
-1,069,400
-35% -$43.9M 0.66% 28
2025
Q4 		$123M Buy
+3,045,200
New +$70.4M 0.73% 33

Other funds holding TERN

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Capitolis Liquid Global Markets's TERN Position: Q2 2026 in Review

Capitolis Liquid Global Markets sold out of Terns Pharmaceuticals (TERN) in Q2 2026, closing a stake of 1,975,800 shares — an estimated $104M sold.

Capitolis Liquid Global Markets first reported a position in TERN in Q4 2025 and held it in 2 quarters. The position peaked at $123M in Q4 2025. 1 fund tracked by Wall St. Rank holds TERN as of Q2 2026.

  • Capitolis Liquid Global Markets reported no remaining Terns Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
  • Capitolis Liquid Global Markets sold 1,975,800 Terns Pharmaceuticals shares in Q2 2026, an estimated $104M.
  • Capitolis Liquid Global Markets first reported a position in Terns Pharmaceuticals in Q4 2025 and held it in 2 quarters.
  • Capitolis Liquid Global Markets's Terns Pharmaceuticals position peaked at $123M in Q4 2025.
  • 1 fund tracked by Wall St. Rank held Terns Pharmaceuticals as of Q2 2026.

Based on Capitolis Liquid Global Markets's 13F filing for Q2 2026, filed 13 Aug 2026.